Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Lucy Scientific Discovery.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Lucy Scientific Discovery
Canada Flag
Country
Country
Canada
Address
Address
Victoria
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Through the acquisition, Lucy will add Wesana’s psilocybin and cannabidiol (CBD) combination investigational therapy, SANA-013 to its existing business of psychedelics manufacturing. SANA-013 is being developed for the treatment of several mental health/CNS-related conditions.


Lead Product(s): Psilocybine,Cannabidiol

Therapeutic Area: Psychiatry/Psychology Product Name: SANA-013

Highest Development Status: PreclinicalProduct Type: Small molecule

Recipient: Wesana Health

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition March 21, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY